Caprock Group’s Hologic HOLX Stock Holding History

Caprock Group’s Portfolio HOLX Stock Details HOLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,683	Closed	-$505K	–	1279
2026 Q1	$505K	Sell	6,683 -6,573	-50%	-$494K	0.01%	747
2025 Q4	$987K	Buy	+13,256	New	+$969K	0.02%	608
2025 Q1	$349K	Buy	5,648 +1,982	+54%	+$131K	0.01%	833
2024 Q4	$264K	Sell	3,666 -366	-9%	-$28.6K	0.01%	849
2024 Q3	$328K	Sell	4,032 -1,781	-31%	-$142K	0.01%	697
2024 Q2	$432K	Buy	+5,813	New	+$436K	0.02%	579
2017 Q3	–	Sell	-4,725	Closed	-$214K	–	464
2017 Q2	$214K	Buy	+4,725	New	+$209K	0.05%	367

Other funds holding HOLX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Caprock Group's HOLX Position: Q2 2026 in Review

Caprock Group sold out of Hologic (HOLX) in Q2 2026, closing a stake of 6,683 shares — an estimated $505K sold.

Caprock Group first reported a position in HOLX in Q2 2017 and held it in 7 quarters. The position peaked at $987K in Q4 2025. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

Caprock Group reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
Caprock Group sold 6,683 Hologic shares in Q2 2026, an estimated $505K.
Caprock Group first reported a position in Hologic in Q2 2017 and held it in 7 quarters.
Caprock Group's Hologic position peaked at $987K in Q4 2025.
3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.